HC Biologics

HC Biologics is a biotechnology and manufacturing startup that was founded in 2015 in the United States. The company's slogan, "Give a second chance through DONATION™," underscores its commitment to advancing patient care through innovative treatment options. HC Biologics has established itself as a trusted global partner, working closely with reputable tissue banks in the USA to develop and deliver high-quality allografts and tissue-based medical products for spinal, orthopedic, oncology, neuro, trauma, dental, and oral-maxillofacial surgeries.

One of HC Biologics' key areas of focus is the provision of top-quality spinal products, with a comprehensive product portfolio designed to offer flexibility and trusted intraoperative options for surgeons. Additionally, the company has been at the forefront of customized orthopedic implants and instruments, leveraging 3-D printing technology to deliver cost-effective solutions that prioritize design innovation and exceptional quality. These efforts aim to enhance surgical efficiency and improve patient outcomes.

Despite the absence of publicly disclosed last investment and last investment investors, HC Biologics' commitment to advancing industry knowledge and capability, coupled with its dedication to providing quality biologics solutions, positions the company as a noteworthy player in the biotechnology and manufacturing sectors.